Abbott Laboratories

NYSE:ABT   3:59:59 PM EDT
-3.22 (-2.70%)
: $117.10 +1.14 (+0.98%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)199.97B
Current PE44.73
Forward PE 22.92
2yr Forward PE 21.43
See more stats
Estimates Current Quarter
Revenue$10.68 Billion
Adjusted EPS$1.28
See more estimates
10-Day MA$119.93
50-Day MA$116.80
200-Day MA$105.24
See more pivots

Abbott Laboratories Stock, NYSE:ABT

100 Abbott Park Road, Abbott Park, Abbott Park, Illinois 60064-6400
United States of America
Phone: +1.224.667.6100
Number of Employees: 109000


Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.